Journal
JOURNAL OF APPLIED PHYSIOLOGY
Volume 112, Issue 9, Pages 1504-1511Publisher
AMER PHYSIOLOGICAL SOC
DOI: 10.1152/japplphysiol.01475.2010
Keywords
orthostatic intolerance; splanchnic blood flow; octreotide
Categories
Funding
- National Aeronautics and Space Administration (NASA) [NNJ04HF45G]
- National Institutes of Health [MO1RR10732]
Ask authors/readers for more resources
Jarvis SS, Florian JP, Curren MJ, Pawelczyk JA. A somatostatin analog improves tilt table tolerance by decreasing splanchnic vascular conductance. J Appl Physiol 112: 1504-1511, 2012. First published February 16, 2012; doi:10.1152/japplphysiol.01475.2010.-Splanchnic hemodynamics and tilt table tolerance were assessed after an infusion of placebo or octreotide acetate, a somatostatin analog whose vascular effects are largely confined to the splanchnic circulation. We hypothesized that reductions in splanchnic blood flow (SpBF) and splanchnic vascular conductance (SpVC) would be related to improvements in tilt table tolerance. In randomized, double-blind, crossover trials, hemodynamic variables were collected in 14 women and 16 men during baseline, 70 degrees head-up tilt (HUT), and recovery. A repeated-measures analysis of variance was used to compare changes from baseline with respect to sex and condition. HUT elicited an increase in heart rate and decreases in mean arterial pressure, cardiac index, stroke index, and systemic vascular conductance. Additionally, SpVC and non-SpVC were lower during HUT. Octreotide reduced SpBF and SpVC and increased systemic vascular conductance and non-SpVC. Changes in SpBF and SpVC between supine and HUT were smaller in women (P < 0.05). Tilt table tolerance was increased after administration of octreotide [median tilt time: 15.7 vs. 37.0 min (P < 0.05) and 21.8 vs. 45.0 min (P < 0.05) for women and men, respectively]. A significant relationship existed between change (Delta) in SpBF (placebo-octreotide) and Delta tilt time in women (Delta tilt time = 2.5-0.0083 Delta SpBF, P < 0.01), but not men (Delta tilt time = 3.41-0.0008 Delta SpBF, P = 0.59). In conclusion, administration of octreotide acetate improved tilt table tolerance, which was associated with a decrease in SpVC. In women, but not men, the magnitude of reduction in SpBF was positively associated with improvements in tilt tolerance.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available